SACCOMANO NICHOLAS A (President and CEO) sold 2.4% of their position (88.00 shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $209.81 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/25/2025ACC: 0001415889-25-018235
DirectorOfficer· President and CEO
Since Oct 2024
-88.00
Net shares
Net seller
$209.81
Total sold
1
Open market trades
0B · 1S
1
Total transactions
88.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−88.00
Price / share
$2.38
Trade value
$209.81
% of position
2.4%
6/23/2025
3.68K→3.59K
Total
Net shares
−88.00
Net value
-$209.81
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/23/2025 | S · Sale | −88.00 | $2.38 | $209.81 | 2.4% | 3.68K | 3.59K |
| Total | −88.00 | -$209.81 | ||||||
Derivative Transactions0
No derivative transactions reported